<DOC>
	<DOC>NCT01808872</DOC>
	<brief_summary>The AQT90 FLEX B-type Natriuretic Peptide (BNP) and N-terminal pro B-type natriuretic peptide (NT-proBNP) Tests are in vitro diagnostic assays intended as an aid in the diagnosis and assessment of the severity of heart failure in point-of-care and laboratory settings. The purpose of the study is to establish the clinical performance of the AQT90 FLEX BNP and NT-proBNP assays for both whole blood and plasma in the intended use population.</brief_summary>
	<brief_title>Clinical Performance Evaluation of AQT90 FLEX BNP and NT-proBNP</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Subject is 21 years of age or older Subject is able to understand information given, and willing and able to voluntarily give their consent to participate in this study Subject has diagnosis of heart failure Subject has Acute Coronary Syndrome (ACS) Subject has been diagnosed and/or treated for malignancy within past 6 months Subject has had cardiac surgery within the past 4 weeks Subject claim of pregnancy Subject's prior participation in this study</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>